Vella / Rizza Clinical Dilemmas in Diabetes

1. Auflage 2011
ISBN: 978-1-4443-4027-3
Verlag: John Wiley & Sons
Format: EPUB
Kopierschutz: Adobe DRM (»Systemvoraussetzungen)

E-Book, Englisch, 176 Seiten, E-Book

Reihe: Clinical Dilemmas

Clinical Dilemmas in Diabetes provides evidence-basedclinical guidance on the most common and problematic areas ofconcern encountered in diagnosing, treating and managing patientswith diabetes. Each chapter is highly topical and has been selecteddue to current interest, specific recent developments, and areas ofcontroversy.
This valuable guide provides assistance in managing thelife-long treatment of diabetes and the complications that oftendevelop in patients. Clinical Dilemmas in Diabetes guidesthe medical team in their decision-making, particularly when thereare conflicts in the treatment for the disease and thecomplications.
Part of the Clinical Dilemmas series, the well-focusedchapter structure allows for quick retrieval of information, andeach opens with a "Learning Points" box to aid easyassimilation of the main issues. With a leading team ofcontributors and editors, Professor Robert A. Rizza is theimmediate Past-President of the American Diabetes Association.
This book is perfect for use on the wards and clinics as well asfor self-study by diabetologists, diabetes specialist nurses,endocrinologists, GPs and cardiologists.

Autoren/Hrsg.

Vella, Adrian

Rizza, Robert A.

Inhaltsverzeichnis

Contributors.
Preface.
Part I Prediabetes and the Diagnosis of Diabetes.
1 Is prediabetes a risk factor or is it a disease?(Kalpana Muthusamy and Adrian Vella).
2 Early diagnosis of type 1 diabetes: Useful or aphyrrhic victory? (Chiara Guglielmi and Paolo Pozzilli).
3 How should secondary causes of diabetes be excluded?(Aonghus O'Loughlin and Sean F. Dinneen).
4 Screening patients with prediabetes and diabetes forcardiovascular disease (Deepika S. Reddy and VivianFonseca).
Part II Initial Evaluation and Management ofDiabetes.
5 What is the role of self-monitoring in diabetes? Isthere a role for postprandial glucose monitoring? How doescontinuous glucose monitoring integrate into clinical practice?(Rami Almokayyad and Robert Cuddihy).
6 The optimal diet for diabetes is? (Maria L.Collazo-Clavell).
7 How to determine when to pursue lifestyle change aloneversus pharmacotherapy at diagnosis? (Galina Smushkin and F.John Service).
8 Insulin sensitizers versus secretagogues as first-linetherapy for diabetes: Rationale for clinical choice (Robert J.Richards, L. Yvonne Melendez-Ramirez, and William T.Cefalu).
9 Are insulin sensitizers useful additions to insulintherapy? (John W. Richard III and Philip Raskin).
10 Is there a role for incretin-based therapy incombination with insulin? (Matheni Sathananthan and AdrianVella).
11 HbA1c: Is it the most important therapeutic target inoutpatient management of diabetes? (Steven A. Smith).
Part III Management of Associated Risk Factors andDisease.
12 Primary therapy for obesity as the treatment of type 2diabetes (Manpreet S. Mundi and Michael D. Jensen).
13 Are statins the optimal therapy for cardiovascularrisk in patients with diabetes? Are triglycerides an importantindependent risk factor for diabetes? (Michael O'Reilly andTimothy O'Brien).
14 The role of bariatric surgery in obese patients withdiabetes: Primary or rescue therapy? (Praveena Gandikota andBlandine Laferrere).
15 Hyperglycemia should be avoided in critical illnessand the postoperative period (Kalpana Muthusamy and John M.Miles).
16 Is there an optimal revascularization strategy indiabetic patients with ischemic heart disease? (Stephen H.McKellar, Morgan L. Brown, and Robert L. Frye).
Index.

Über Autor(innen)

Adrian Vella Associate Professor of Medicine, Mayo ClinicCollege of Medicine, Rochester, USA
Robert Rizza Professor of Medicine and Division Chair forEndocrinology, Mayo Clinic College of Medicine, Rochester,USA